A recent analysis attempts to clarify whether the growing use of immune checkpoint inhibitors to treat metastatic cancer was associated with an increased risk for second primary cancers.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ici-use-and-secondary-cancer-risk-there-link-2026a10003nm?src=rss
Author :
Publish date : 2026-02-05 08:22:00
Copyright for syndicated content belongs to the linked Source.
